Erratum to: Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma
In the original publication of the article, the frequency of loss-of-function mutations in AXIN1, AXIN2 and APC was underestimated in Table 1. The correct frequencies of these mutations in HCC are 10.4, 3.3, and 1.4%, respectively (in the following page).
On page 421, in the section of ‘‘Aberrant activation of Wnt/b-catenin signaling during HCC’’, the sentence following ‘‘Missense, insertion, or partial deletions within CTNNB1 exon 3 lead to … stabilization of b-catenin in the cytoplasm’’ should be read as ‘‘Less frequently, loss-offunction mutation of AXIN1, AXIN2, or APC is found in 10.4, 3.3, and 1.4% of HCCs respectively…’’.
|Persistent URL||dx.doi.org/10.1007/s00535-017-1392-4, hdl.handle.net/1765/102394|
|Journal||Journal of Gastroenterology|
|Note||Erratum to: J Gastroenterol (2017) 52:419–431 DOI 10.1007/s00535-016-1299-5.|
Wang, W, Pan, Q, Fuhler, G.M, Smits, M.J.M, & Peppelenbosch, M.P. (2017). Erratum to: Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma. Journal of Gastroenterology, 1–2. doi:10.1007/s00535-017-1392-4